Estimate of the most common bacteria cause of UTI and effective drug in Alrefaai City

Author:

Al‑khegane Murtadha A.1,Abed Ali Wisam Jasim1,Ashour Zainab1,Turki Ibrahim Dip2,K. Najim Murtadha2,Lahhob Qais R.3

Affiliation:

1. Department of Pathological Analysis, College of Science, University of Sumer, Dhi Qar, Alrefaai, Iraq

2. AlRifaai General Hospital. Iraq

3. National University of Science and Technology, Nasiriyah, Iraq

Abstract

Background: Urinary Tract Infection is a worldwide prevalence disease that infects both males and females in different ratios. Escherichia coli is the most infectious pathogen, followed by Klebsiella and Pseudomonas. Through time bacteria increase their resistance to most antibiotics, increasing bacterial prevalence and pathogenesis. Fifty patients with UTI symptoms were randomly selected in Alrefaai Hospital from October 2021 to April 2022. A 10-15 ml urine sample was collected from each patient and cultured to calculate colony forming unit and detect the type of bacteria with biochemical tests. Most patients were female 66% compared to male 34% with age groups 1-30 years 68% and those more than other groups. Escherichia coli is the most prevalent, 54%, while the second one is Staphylococcus aureus 20%, then Coagulase -ve Staphylococcus 14% and less infection was with Klebsiella and Proteus, 6%. Antibiotic Imipenem, Chloramphenicol, Gentamycin, Norfloxacin, Ciprofloxacin and Tobramycin play highly effective roles on most bacteria. We found that most patients with UTI were from the city center and in the age group 1-30 years. The most prevalent pathogens of UTI were Escherichia coli and then Staphylococcus aureus. Almost Imipenem, Chloramphenicol, Gentamycin, Norfloxacin, Ciprofloxacin and Tobramycin are the best effective antibiotics against our study's bacteria. Keywords: Urinary Tract Infection, Recurrent UTI, Alrefaai city, Antibiotic susceptibility.

Publisher

Clinical Biotec

Subject

Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3